Number of the records: 1
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
SYS 0189510 LBL 00000naa^^22^^^^^^^^450 005 20230814153415.7 100 $a 20230623d2023 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study $f Antonelli L., Mego M. ... [et al.] 305 $a Eur J Cancer. 2023 Mar;182:144-154 463 -1
$1 001 sllk_un_cat*0188969 $1 011 $a 1336-8176 $1 200 1 $a Onkológia $v Roč. 18, č. 2 (2023), s. 160-161 $1 210 $a Bratislava $c SOLEN $d 2023 $1 215 $a s. 83-162 606 1-
$3 sllk_un_auth*d009373 $a nádory z germinatívnych a embryonálnych buniek $2 mesh 606 1-
$3 sllk_un_auth*d013724 $a teratóm $2 mesh 606 1-
$3 sllk_un_auth*d018365 $a nádor reziduálny $2 mesh 606 2-
$3 sllk_un_auth*d015996 $a miera prežívania $2 mesh 608 $3 sllk_un_auth*d004740 $a abstrakt v angličtine $2 mesh 610 2-
$a nádory zo zárodočných buniek neseminomatózne metastatické 610 2-
$a vyhodnotenie súboru pacientov retrospektívne 701 -1
$3 sllk_un_auth*p0043304 $a Mego $b Michal $p Klinika klinickej onkológie NOÚ, Bratislava $4 100 711 02
$3 sllk_un_auth*0012742 $a Redakcia Onkológia $4 010 801 -0
$a SK $b BA006 $c 20230623 $g AACR2
Number of the records: 1